IPO - Bellevue Life Sciences Acquisition Corp.
Add to your watchlist
Upgrade to receive email alerts for new filings
Form Type: DRSLTR
Filing Date: 2023-12-21
Corporate Action: Ipo
Type: New
Accession Number: 000095012323011270
Filing Summary: Bellevue Life Sciences Acquisition Corp. has submitted a draft Registration Statement on Form S-4 to the staff of the U.S. Securities and Exchange Commission for non-public review. The company intends to publicly file its registration statement along with the non-public draft submission at least 48 hours prior to any effective time and date requested. The correspondence was prepared by K&L Gates LLP and includes contact information for the firm's representative, Gary J. Kocher.
Additional details:
Registration Statement Type: S-4
Confidential Submission: true
Comments
No comments yet. Be the first to comment!